Nuclear medicine scientist joins MSU/IQ

August 10, 2017

Kurt Zinn

Kurt R. Zinn, D.V.M., M.S., Ph.D., joined Michigan State University’s Department of Biomedical Engineering and new Institute for Quantitative Health Science and Engineering (IQ) as chief of the Chemical Biology Division. He is also a professor in the departments of Radiology and Small Animal Clinical Sciences.

Zinn’s research focuses on the development of molecular approaches for cancer diagnosis, treatment monitoring, and therapy. With experience in more than 10 Phase One clinical trials, Zinn expects to conduct clinical trials in both veterinary and human medicine. He also will use radionuclides harvested from MSU’s Facility for Rare Isotope Beams to specifically target tumors for radiation therapy.

Prior to joining MSU, Zinn was professor of radiology at the University of Alabama at Birmingham. He also served as director of the university’s Laboratory of Multimodality Imaging and the Preclinical Imaging Shared Facility. Additionally, he served as director of Radiology’s Division of Advanced Medical Imaging Research. As a scientist at the University of Missouri-Columbia Research Reactor, he developed methods for producing high specific activity radionuclides.

In 2015, he earned a Distinguished Investigator Award from the Academy of Radiology Research.
Zinn earned his bachelor’s degree in chemistry, doctorate in veterinary medicine, a master of science degree in chemistry, and a doctoral degree in biochemistry all at the University of Missouri-Columbia.
Zinn was hired through the MSU Global Impact Initiative created to recruit more than 100 new faculty investigators to accelerate finding solutions to the global challenges we face in energy, health, education, the environment, national security, and global development.

IQ is a research collaboration among the colleges of Engineering, Human Medicine and Natural Science at Michigan State University dedicated to developing intelligent solutions to enable improved control of health and disease. This alliance, combined with other colleges and departments and MSU’s unique status of having three medical schools – College of Human Medicine, College of Osteopathic Medicine and College of Veterinary Medicine – makes the university well-positioned to produce novel biomedical solutions to reduce healthcare costs and dramatically improve patient care.